An electronic pressure-meter nociception paw test for mice
An electronic pressure-meter nociception paw test for mice
复制标题
DOI:
10.1590/s0100-879x2004000300018
复制
发表时间:
2004-03-01
影响因子:
2.3
通讯作者:
Ferreira, S.H.
中科院分区:
文献类型:
--
作者:
Cunha, T.M.;Verri Jr., W.A.;Ferreira, S.H.
The aim of the present investigation was to describe and validate an electronic mechanical test for quantification of the intensity of inflammatory nociception in mice. The electronic pressure-meter test consists of inducing the animal hindpaw flexion reflex by poking the plantar region with a polypropylene pipette tip adapted to a hand-held force transducer. This method was compared to the classical von Frey filaments test in which pressure intensity is automatically recorded after the nociceptive hindpaw flexion reflex. The electronic pressure-meter and the von Frey filaments were used to detect time versus treatment interactions of carrageenin-induced hypernociception. In two separate experiments, the electronic pressure-meter was more sensitive than the von Frey filaments for the detection of the increase in nociception (hypernociception) induced by small doses of carrageenin (30 mug). The electronic pressure-meter detected the antinociceptive effect of nonsteroidal drugs in a dose-dependent manner. Indomethacin administered intraperitoneally (1.8-15 mg/kg) of intraplantarly (30-300 mug/ paw) prevented the hypersensitive effect of carrageenin (100 mug/ paw). The electronic pressure-meter also detected the hypernociceptive effect of prostaglandin E-2 (PGE(2); 10-100 ng) in a dose-dependent manner. The hypernociceptive, effect of PGE(2) (100 ng) was blocked by dipyrone (160 and 320 mug/paw) but not by intraplantar administration of indomethacin (300 mug/paw). The present results validate the use of the electronic pressure-meter as more sensitive than the von Frey filaments in mice. Furthermore, it is an objective and quantitative nociceptive test for the evaluation of the peripheral antinociceptive effect of anti-inflammatory analgesic drugs, which inhibit prostaglandin synthesis (indomethacin) or directly block the ongoing hypernociception (dipyrone).